These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 27352936

  • 1. Effect of risperidone on plasma d-serine concentration in rats post-administered with d-serine.
    Onozato M, Nakazawa H, Hakariya H, Shishikura M, Nagashima C, Ishimaru K, Sakamoto T, Iizuka H, Ichiba H, Fukushima T.
    Life Sci; 2016 Aug 01; 158():98-103. PubMed ID: 27352936
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Relationship between clinical efficacy and plasma concentration-dose ratio of risperidone in patients with schizophrenia.
    Chen Q, Min J, Yin H, Xia W, Shen Y, Shu M.
    Int Clin Psychopharmacol; 2024 Jan 01; 39(1):17-22. PubMed ID: 37551602
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Low doses of risperidone and morphine interact to produce more analgesia and greater extrapyramidal effects in rats.
    DiPirro JM, Thompson AC, Suarez M, Leo RJ.
    Neurosci Lett; 2011 Feb 18; 490(1):21-6. PubMed ID: 21167255
    [Abstract] [Full Text] [Related]

  • 14. The behavioral and neurochemical effects of a novel D-amino acid oxidase inhibitor compound 8 [4H-thieno [3,2-b]pyrrole-5-carboxylic acid] and D-serine.
    Smith SM, Uslaner JM, Yao L, Mullins CM, Surles NO, Huszar SL, McNaughton CH, Pascarella DM, Kandebo M, Hinchliffe RM, Sparey T, Brandon NJ, Jones B, Venkatraman S, Young MB, Sachs N, Jacobson MA, Hutson PH.
    J Pharmacol Exp Ther; 2009 Mar 18; 328(3):921-30. PubMed ID: 19088300
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Adjunctive alpha2-adrenoceptor blockade enhances the antipsychotic-like effect of risperidone and facilitates cortical dopaminergic and glutamatergic, NMDA receptor-mediated transmission.
    Marcus MM, Wiker C, Frånberg O, Konradsson-Geuken A, Langlois X, Jardemark K, Svensson TH.
    Int J Neuropsychopharmacol; 2010 Aug 18; 13(7):891-903. PubMed ID: 19835668
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comments on 'The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia'.
    Hashimoto K.
    J Psychopharmacol; 2010 Jul 18; 24(7):1133-4. PubMed ID: 19939869
    [No Abstract] [Full Text] [Related]

  • 20. Comparative effects of the antipsychotics sulpiride and risperidone in female rats on energy balance, body composition, fat morphology and macronutrient selection.
    Baptista T, de Baptista EA, Lalonde J, Plamondon J, Kin NM, Beaulieu S, Joober R, Richard D.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec 18; 28(8):1305-11. PubMed ID: 15588757
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.